LEADER 01561nas  2200517-a 450 
001 9910168745403321
005 20200328111424.2
011   $a2041-6806
035   $a(OCoLC)745407773
035   $a(CKB)2670000000067781
035   $a(CONSER)--2011243558
035   $a(DE-599)ZDB2590690-2
035   $a(EXLCZ)992670000000067781
100   $a20110222b20112015  ---         -
101 0 $aeng
181   $ctxt$2rdacontent
182   $cn$2rdamedia
200 00$aClinical investigation
210   $aLondon $cFuture Science
300   $aRefereed/Peer-reviewed
311 08$a2041-6792 
531 10$aClin Investig (Lond)
606   $aDrugs$xTesting$vPeriodicals
606   $aDrug development$vPeriodicals
606   $aClinical trials$vPeriodicals
606   $aClinical trials$2fast$3(OCoLC)fst00864429
606   $aDrug development$2fast$3(OCoLC)fst00898670
606   $aDrugs$xTesting$2fast$3(OCoLC)fst00898940
606   $aClinical Trials as Topic
606   $aDrugs, Investigational
606   $aOutcome Assessment, Health Care
608   $aPeriodicals.$2fast
608   $aPeriodical.
615  0$aDrugs$xTesting
615  0$aDrug development
615  0$aClinical trials
615  7$aClinical trials.
615  7$aDrug development.
615  7$aDrugs$xTesting.
615 12$aClinical Trials as Topic.
615 22$aDrugs, Investigational.
615 22$aOutcome Assessment, Health Care.
906   $aJOURNAL
912   $a9910168745403321
996   $aClinical investigation$91942577
997   $aUNINA